Project Grant R01DA061291
Award Date
9/1/24
Completion Date
7/31/29
Dollars Obligated
$443K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
New Jersey, USA
Similar Awards
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $395,995 to Oregon Health & Science University (OHSU) to conduct a longitudinal study examining the reciprocal relationships between cannabis use, sleep, and the hypothalamic-pituitary-adrenal (HPA) axis. The study will enroll 60 participants, including healthy controls and those with moderate and severe cannabis use disorder, to assess the...
This $376,078 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support research to explore the relationship between cannabis use for coping purposes and quantity/frequency of cannabis use. The 5-year study, set to commence on August 1, 2024, will be conducted by the University of Colorado. Key objectives include: Experimentally testing whether cannabis use increases after stress induction among...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to investigate the impact of prenatal exposure to cannabis on childhood adiposity and cardiometabolic health outcomes. The $234,000 award, with a performance period from August 2024 to July 2026, will support a study using a well-characterized observational cohort in Colorado to measure the levels of delta-9-tetrahydrocannabinol (D9-THC) and...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will provide $1,178,880 to the University of Washington to conduct a comprehensive longitudinal study examining the mechanisms of a high-risk feedback cycle involving nonmedical use of prescription stimulants (NMPS), alcohol use, cannabis use, academic stress, and sleep difficulties among college students. The 5-year study, which commenced on May 15,...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), is focused on evaluating the safety of prescription sleep medications in children, adolescents, and young adults with Attention Deficit Hyperactivity Disorder (ADHD). The $633,671 award to Rutgers, The State University of New Jersey, will fund a 5-year study (May 1, 2025 - Feb 28, 2030) to: 1) examine nationwide patterns of sleep medication use and dose...
The National Institute on Drug Abuse (NIDA) awarded a $1,980,270 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Regents of the University of Minnesota. The award, which runs from September 30, 2024 to May 31, 2029, will fund an observational study to assess the neurobehavioral impacts of medical cannabis use in a sample of 120 patients aged 35-65 who are being treated for chronic pain in Minnesota. The study aims to evaluate the effects of medical...
This $668,110 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund the development and acceptability testing of a technology-based intervention to reduce cannabis misuse among college students. The project aims to refine an existing intervention that provides information on cannabis products, marketing, laws, and risks to increase young adults' cannabis literacy. The research will involve focus groups with...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is providing $188,482 to the University of Colorado-Denver to study the prevalence and effects of cannabidiol (CBD) use during pregnancy. The key objectives are to: 1) Estimate the prevalence of CBD use by trimester in a sample of 800 pregnant women receiving prenatal care; 2) Characterize the demographics, mental/physical health, and cannabinoid use...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $149,000 in funding to the University of Oregon to conduct a longitudinal study examining the developmental trajectories of autonomic reactivity and regulation in children exposed prenatally to cannabis and tobacco. The key objectives of the study are to: 1) examine changes in parasympathetic nervous system functioning from infancy to early...
This federal Project Grant award, ID R01DA059527, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $2,118,992 grant will fund a prospective investigation into the effects of cannabis use on reward and pain neurocircuits in adolescents with depression. The research aims to understand the relationships between cannabis use and depression in adolescence, which may inform prevention and intervention strategies for...